statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	441
RU - Federazione Russa	365
SG - Singapore	180
IT - Italia	144
CN - Cina	100
BR - Brasile	94
GB - Regno Unito	43
HK - Hong Kong	40
DE - Germania	39
VN - Vietnam	34
FI - Finlandia	31
SE - Svezia	26
IE - Irlanda	23
TR - Turchia	23
FR - Francia	20
PL - Polonia	17
KR - Corea	15
ID - Indonesia	14
CA - Canada	11
NL - Olanda	11
IQ - Iraq	10
AT - Austria	8
JP - Giappone	8
MX - Messico	8
HR - Croazia	7
TG - Togo	7
AE - Emirati Arabi Uniti	6
IN - India	6
AR - Argentina	5
BJ - Benin	5
ZA - Sudafrica	5
CH - Svizzera	4
GR - Grecia	4
SA - Arabia Saudita	4
AU - Australia	3
BD - Bangladesh	3
JO - Giordania	3
MK - Macedonia	3
UA - Ucraina	3
AL - Albania	2
AZ - Azerbaigian	2
CL - Cile	2
CZ - Repubblica Ceca	2
EC - Ecuador	2
IR - Iran	2
KE - Kenya	2
KZ - Kazakistan	2
MA - Marocco	2
PK - Pakistan	2
UY - Uruguay	2
UZ - Uzbekistan	2
AM - Armenia	1
AO - Angola	1
BE - Belgio	1
BY - Bielorussia	1
CO - Colombia	1
CR - Costa Rica	1
DK - Danimarca	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
ET - Etiopia	1
IL - Israele	1
KW - Kuwait	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MU - Mauritius	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
PE - Perù	1
PS - Palestinian Territory	1
PY - Paraguay	1
QA - Qatar	1
RO - Romania	1
SN - Senegal	1
TZ - Tanzania	1
Totale	1.822

Nome	#
Exploring promising biomarkers in multiple sclerosis	241
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity	182
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients	176
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis	148
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis	144
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage	120
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs	115
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain	112
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis	109
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis	108
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis	105
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?	99
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF	98
Breakthrough COVID-19 infection in people with MS after SARS-CoV-2 vaccination: Should we still be concerned?	85
Totale	1.842

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	44	0	0	0	0	0	7	7	2	5	0	5	18
2021/2022	58	1	19	0	14	0	1	5	3	1	1	3	10
2022/2023	153	6	16	9	16	8	30	3	19	31	1	10	4
2023/2024	173	13	10	10	21	10	21	21	13	7	13	26	8
2024/2025	568	19	35	30	103	33	50	55	26	87	28	37	65
2025/2026	801	55	65	69	233	358	21	0	0	0	0	0	0
Totale													1.842

CATALOGO DEI PRODOTTI DELLA RICERCA